Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A13885 | 29710028 | J Nutr Sci Vitaminol (Tokyo) | Vitamin D Deficiency Increases Lipogenesis and Reduces Beta-Oxidation in the Liver of Diet-Induced Obese Mice. | 2018 | Details |
| A13894 | 29705134 | Biochimie | Increase in liver cytosolic lipases activities and VLDL-TAG secretion rate do not prevent the non-alcoholic fatty liver disease in cafeteria diet-fed rats. | 2018 | Details |
| A13896 | 29704818 | Cytokine | Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease. | 2018 | Details |
| A13898 | 29704259 | Hepatology | TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice. | 2018 | Details |
| A13900 | 29702590 | Int J Mol Sci | Insulin-Like Growth Factor (IGF) System in Liver Diseases. | 2018 | Details |
| A13907 | 29699606 | BMB Rep | Insulin receptor substrate 2: a bridge between Hippo and AKT pathways. | 2018 | Details |
| A13908 | 29698567 | Hepatology | Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6. | 2018 | Details |
| A13916 | 29696060 | J Med Life | Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications. | 2018 | Details |
| A13918 | 29693586 | Nutrients | Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats. | 2018 | Details |
| A13922 | 29690638 | Nutrients | Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity. | 2018 | Details |
| A13931 | 29683979 | Eur J Gastroenterol Hepatol | Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. | 2018 | Details |
| A13949 | 29674209 | Steroids | Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone. | 2018 | Details |
| A13961 | 29670908 | Biomed Res Int | Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis. | 2018 | Details |
| A13962 | 29670844 | Adv Pharm Bull | The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13966 | 29666152 | J Endocrinol | Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD. | 2018 | Details |
| A13970 | 29665034 | Hepatology | Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort. | 2018 | Details |
| A13972 | 29663549 | J Gastroenterol Hepatol | Ostreolysin induces browning of adipocytes and ameliorates hepatic steatosis. | 2018 | Details |
| A13975 | 29662003 | Int J Mol Sci | PPAR Agonists and Metabolic Syndrome: An Established Role? | 2018 | Details |
| A13980 | 29660503 | Redox Biol | High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease. | 2018 | Details |
| A13984 | 29657020 | Clin Res Hepatol Gastroenterol | Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice. | 2018 | Details |
| A13989 | 29655677 | Phytomedicine | An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome. | 2018 | Details |
| A13992 | 29654490 | Mol Neurobiol | Long-Term, Fructose-Induced Metabolic Syndrome-Like Condition Is Associated with Higher Metabolism, Reduced Synaptic Plasticity and Cognitive Impairment in Octodon degus. | 2018 | Details |
| A13998 | 29652564 | J Am Coll Nutr | Examining the Relationship Between Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome in Nondiabetic Subjects. | 2018 | Details |
| A13999 | 29651819 | J Korean Med Sci | Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity. | 2018 | Details |
| A14003 | 29643297 | J Vet Med Sci | Investigation of pharmacological responses to anti-diabetic drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis (NASH) model. | 2018 | Details |
| A14007 | 29641459 | Molecules | An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14009 | 29636553 | Hypertens Res | The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review. | 2018 | Details |
| A14012 | 29634665 | Eur J Gastroenterol Hepatol | Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring. | 2018 | Details |
| A14013 | 29634314 | Am J Physiol Endocrinol Metab | Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis. | 2018 | Details |
| A14022 | 29631096 | Biochim Biophys Acta Mol Cell Biol Lipids | Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis. | 2018 | Details |
| A14028 | 29628274 | Trends Pharmacol Sci | Macrophage-Targeted Therapeutics for Metabolic Disease. | 2018 | Details |
| A14030 | 29626628 | Free Radic Biol Med | Hepatocyte-specific deletion of LASS2 protects against diet-induced hepatic steatosis and insulin resistance. | 2018 | Details |
| A14041 | 29620197 | Mol Med Rep | Identification of key genes in non‑alcoholic fatty liver disease progression based on bioinformatics analysis. | 2018 | Details |
| A14042 | 29620148 | Int J Mol Med | Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS. | 2018 | Details |
| A14043 | 29619530 | Diabetologia | Can targeting ANGPTL proteins improve glucose tolerance? | 2018 | Details |
| A14046 | 29615042 | Lipids Health Dis | Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis. | 2018 | Details |
| A14052 | 29609136 | Cytokine | Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses. | 2018 | Details |
| A14053 | 29608898 | Eur J Pharmacol | Canagliflozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation. | 2018 | Details |
| A14056 | 29608255 | Liver Int | Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease. | 2018 | Details |
| A14057 | 29607802 | Public Health Nutr | Intakes of magnesium, calcium and risk of fatty liver disease and prediabetes. | 2018 | Details |
| A14062 | 29604480 | Atherosclerosis | Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction. | 2018 | Details |
| A14071 | 29602794 | Diabetes Care | Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. | 2018 | Details |
| A14072 | 29602237 | J Cell Mol Med | NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis. | 2018 | Details |
| A14073 | 29601997 | Contemp Clin Trials | Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology. | 2018 | Details |
| A14081 | 29599925 | Oncotarget | A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice. | 2018 | Details |
| A14082 | 29599631 | Malays J Med Sci | The Effect of Amygdalin on Endoplasmic Reticulum (ER) Stress Induced Hepatic Steatosis in Mice. | 2018 | Details |
| A14086 | 29595666 | Medicine (Baltimore) | Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD). | 2018 | Details |
| A14087 | 29594475 | Eur J Nutr | Individual fatty acids in erythrocyte membranes are associated with several features of the metabolic syndrome in obese children. | 2018 | Details |
| A14088 | 29594435 | Eur J Nutr | Higher serum carotenoids associated with improvement of non-alcoholic fatty liver disease in adults: a prospective study. | 2018 | Details |
| A14091 | 29593573 | Front Physiol | Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models. | 2018 | Details |
| A14092 | 29592806 | J Biomed Sci | β-aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway. | 2018 | Details |
| A14094 | 31089541 | J Obes Metab Syndr | Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes. | 2018 | Details |
| A14095 | 29590379 | J Clin Endocrinol Metab | Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes. | 2018 | Details |
| A14096 | 29590099 | PLoS Med | Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. | 2018 | Details |
| A14100 | 29587769 | Reprod Biol Endocrinol | Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study. | 2018 | Details |
| A14101 | 29584615 | J Pediatr Endocrinol Metab | Metabolic and genetic markers' associations with elevated levels of alanine aminotransferase in adolescents. | 2018 | Details |
| A14102 | 29584449 | Crit Rev Food Sci Nutr | Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. | 2018 | Details |
| A14105 | 29580823 | Mol Cell Endocrinol | GW0742 (PPAR-beta agonist) attenuates hepatic endoplasmic reticulum stress by improving hepatic energy metabolism in high-fat diet fed mice. | 2018 | Details |
| A14115 | 29575149 | J Cell Biochem | Exercise decreases CLK2 in the liver of obese mice and prevents hepatic fat accumulation. | 2018 | Details |
| A14116 | 29575055 | J Cell Biochem | MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease. | 2018 | Details |
| A14118 | 29574933 | Clin Exp Pharmacol Physiol | The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients. | 2018 | Details |
| A14124 | 29573006 | Hepatology | Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice. | 2018 | Details |
| A14128 | 29572342 | J Pharmacol Exp Ther | Protectin DX Ameliorates Hepatic Steatosis by Suppression of Endoplasmic Reticulum Stress via AMPK-Induced ORP150 Expression. | 2018 | Details |
| A14129 | 29572095 | J Hepatol | A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. | 2018 | Details |
| A14130 | 29571977 | Diabetes Metab Syndr | Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. | 2018 | Details |
| A14131 | 29571924 | J Hepatol | High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. | 2018 | Details |
| A14133 | 29570139 | J Pediatr Gastroenterol Nutr | Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States. | 2018 | Details |
| A14136 | 29568887 | Int J Mol Med | Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease. | 2018 | Details |
| A14141 | 29566909 | Best Pract Res Clin Gastroenterol | NAFLD, Helicobacter species and the intestinal microbiome. | 2017 | Details |
| A14143 | 29565507 | Eur Rev Med Pharmacol Sci | Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men. | 2018 | Details |
| A14144 | 29565153 | Nutr Hosp | Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents. | 2018 | Details |
| A14149 | 29563854 | Mediators Inflamm | Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14153 | 29561981 | Arq Gastroenterol | MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY. | 2018 | Details |
| A14156 | 29560693 | Acta Gastroenterol Belg | Apoptosis and Disease Severity is Associated with Insulin Resistance in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14159 | 29558460 | Int J Mol Sci | p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. | 2018 | Details |
| A14172 | 29552625 | Cell Mol Gastroenterol Hepatol | Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). | 2017 | Details |
| A14173 | 29552621 | Cell Mol Gastroenterol Hepatol | Ferroportin Expression in Adipocytes Does Not Contribute to Iron Homeostasis or Metabolic Responses to a High Calorie Diet. | 2018 | Details |
| A14176 | 29550812 | Cell Physiol Biochem | Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14177 | 29550470 | Biochem Biophys Res Commun | PPARγ alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway. | 2018 | Details |
| A14181 | 29547708 | Atherosclerosis | Resolution of fatty liver and weight loss: Independent associations with changes in serum lipids and apolipoproteins. | 2018 | Details |
| A14183 | 29547047 | Endocr Pract | PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES. | 2018 | Details |
| A14190 | 29538359 | Pediatr Res | Gut microbiota in adolescents and the association with fatty liver: the EPOCH study. | 2018 | Details |
| A14195 | 29534506 | Nutrients | Saccharin Increases Fasting Blood Glucose but Not Liver Insulin Resistance in Comparison to a High Fructose-Fed Rat Model. | 2018 | Details |
| A14201 | 29527789 | Diabetes Obes Metab | Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2018 | Details |
| A14203 | 29527255 | World J Hepatol | Glycogenic hepatopathy: A narrative review. | 2018 | Details |
| A14207 | 29526751 | Biochem Biophys Res Commun | Enoyl coenzyme A hydratase 1 protects against high-fat-diet-induced hepatic steatosis and insulin resistance. | 2018 | Details |
| A14218 | 29519663 | Surg Obes Relat Dis | Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? | 2017 | Details |
| A14225 | 29516226 | Eur J Nutr | Chronic fructose intake does not induce liver steatosis and inflammation in female Sprague-Dawley rats, but causes hypertriglyceridemia related to decreased VLDL receptor expression. | 2018 | Details |
| A14229 | 29514661 | J Transl Med | Physiological and molecular effects of interleukin-18 administration on the mouse kidney. | 2018 | Details |
| A14230 | 29514047 | Biochim Biophys Acta Mol Basis Dis | Deletion of NLRX1 increases fatty acid metabolism and prevents diet-induced hepatic steatosis and metabolic syndrome. | 2018 | Details |
| A14234 | 29512720 | Mol Med Rep | Alogliptin alleviates hepatic steatosis in a mouse model of nonalcoholic fatty liver disease by promoting CPT1a expression via Thr172 phosphorylation of AMPKα in the liver. | 2018 | Details |
| A14235 | 29511882 | Curr Atheroscler Rep | Cardiometabolic Effects of Anti-obesity Pharmacotherapy. | 2018 | Details |
| A14236 | 29511669 | Biomed Res Int | Ethanol Extract from Ulva prolifera Prevents High-Fat Diet-Induced Insulin Resistance, Oxidative Stress, and Inflammation Response in Mice. | 2018 | Details |
| A14238 | 29510489 | Int J Mol Sci | Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. | 2018 | Details |
| A14240 | 29509436 | Am J Physiol Endocrinol Metab | Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. | 2018 | Details |
| A14242 | 29508519 | Mol Nutr Food Res | Caffeic Acid Phenethyl Ester Improves Metabolic Syndrome by Activating PPAR-γ and Inducing Adipose Tissue Remodeling in Diet-Induced Obese Mice. | 2018 | Details |
| A14243 | 29507903 | Hepatol Commun | Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease. | 2018 | Details |
| A14247 | 29507217 | Proc Natl Acad Sci U S A | High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. | 2018 | Details |
| A14248 | 29507043 | J Endocrinol | Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver. | 2018 | Details |
| A14251 | 29505553 | J Clin Gastroenterol | Prediction of Liver Steatosis Applying a New Score in Subjects from the Brazilian Longitudinal Study of Adult Health. | 2020 | Details |